Language:

Zinc and COVID-19: Basis of Current Clinical Trials

Biological trace element research, 2021-08, Vol.199 (8), p.2882-2892 [Peer Reviewed Journal]

Springer Science+Business Media, LLC, part of Springer Nature 2020 ;Springer Science+Business Media, LLC, part of Springer Nature 2020. ;ISSN: 0163-4984 ;EISSN: 1559-0720 ;DOI: 10.1007/s12011-020-02437-9 ;PMID: 33094446

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Zinc and COVID-19: Basis of Current Clinical Trials
Author: Pal, Amit ; Squitti, Rosanna ; Picozza, Mario ; Pawar, Anil ; Rongioletti, Mauro ; Dutta, Atanu Kumar ; Sahoo, Sibasish ; Goswami, Kalyan ; Sharma, Praveen ; Prasad, Rajendra
Subjects: Antioxidants ; Antiviral agents ; Biochemistry ; Biomedical and Life Sciences ; Biotechnology ; Clinical trials ; Coronaviruses ; COVID-19 ; Cytokines ; Diseases ; Economics ; Immune system ; Immunity ; Inflammation ; Inflammatory response ; Life Sciences ; Nutrition ; Oncology ; Pandemics ; Viral diseases ; Zinc
Is Part Of: Biological trace element research, 2021-08, Vol.199 (8), p.2882-2892
Description: Coronavirus disease-2019 (COVID-19) pandemic continues to threaten patients, societies, and economic and healthcare systems around the world. Like many other diseases, the host immune system determines the progress of COVID-19 and fatality. Modulation of inflammatory response and cytokine production using immunonutrition is a novel concept that has been applied to other diseases as well. Zinc, one of the anti-inflammatory and antioxidant micronutrient found in food with well-established role in immunity, is currently being used in some clinical trials against COVID-19. This review integrates the contemporary studies of role of zinc in antiviral immunity along with discussing its potential role against COVID-19, and ongoing COVID-19 clinical trials using zinc.
Publisher: New York: Springer US
Language: English
Identifier: ISSN: 0163-4984
EISSN: 1559-0720
DOI: 10.1007/s12011-020-02437-9
PMID: 33094446
Source: AUTh Library subscriptions: ProQuest Central

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Zinc and COVID-19: Basis of Current Clinical Trials

Springer Science+Business Media, LLC, part of Springer Nature 2020 ;Springer Science+Business Media, LLC, part of Springer Nature 2020. ;ISSN: 0163-4984 ;EISSN: 1559-0720 ;DOI: 10.1007/s12011-020-02437-9 ;PMID: 33094446

Searching Remote Databases, Please Wait